Medicine and Dentistry
Health Care Cost
84%
Left Ventricular Assist Device
77%
Heart Surgery
73%
Ischemic Mitral Valve Regurgitation
65%
Mitral Valve Repair
62%
Congestive Heart Failure
58%
Quality of Life
53%
Coronary Artery Bypass Graft
44%
Apoplexy
44%
Cardiothoracics
44%
Hazard Ratio
44%
Mitral Valve Surgery
41%
Mitral Insufficiency
37%
Surgery
37%
Infection
35%
Aortic Valve Replacement
34%
Randomized Clinical Trial
33%
Adverse Event
33%
Cost-Effectiveness Analysis
32%
Atrial Fibrillation
32%
Permanent Pacemaker
27%
Abdominal Aortic Aneurysm
27%
Pacemaker Implantation
26%
Assisted Circulation
26%
Odds Ratio
26%
Mitral Valve Replacement
22%
Endovascular Aneurysm Repair
21%
End-Systolic Volume
20%
Diabetes
20%
Heart Transplantation
19%
COVID-19
19%
Abdominal Aortic Aneurysm Repair
19%
Interventional Therapy
18%
Medicare
17%
Clinical Trial
17%
Cerebral Arteriovenous Malformation
16%
Revascularization
16%
Saphenous Vein Graft
15%
Tricuspid Insufficiency
15%
Mitral Valve
14%
Intimal Hyperplasia
14%
Cohort Analysis
14%
Chronic Obstructive Pulmonary Disease
13%
Randomized Controlled Trial
13%
Tricuspid Annuloplasty
13%
Ventricular Assist Device
13%
Comorbidity
13%
Disease
13%
Antibiotic Prophylaxis
13%
Carotid Endarterectomy
12%
Keyphrases
Mitral Valve Repair
100%
Confidence Interval
75%
Left Ventricular Assist Device
72%
Cardiac Surgery
71%
Randomized Trial
66%
Quality of Life
52%
Cardiothoracic Surgical Trials Network
46%
Coronary Artery Bypass Grafting
42%
Hazard Ratio
38%
Severe Ischemic Mitral Regurgitation
37%
Medical Management
37%
Ruptured Abdominal Aortic Aneurysm (rAAA)
35%
Cost-effectiveness
34%
Clinical Outcomes
31%
Risk Factors
31%
Randomized Clinical Trial
31%
Hospitalization
28%
Surgical Aortic Valve Replacement
26%
Left Ventricular Assist Device Implantation
26%
COVID-19
25%
Medicaid
24%
Decision Analysis
24%
Atrial Fibrillation
22%
Surgical Treatment
22%
Hospital Costs
22%
Transplantation
22%
Destination Therapy
21%
Permanent Pacemaker Implantation
20%
Acute Decompensated Heart Failure
20%
Readmission
20%
Incremental Cost-effectiveness Ratio
20%
Odds Ratio
20%
Left Ventricular End-diastolic Volume (LVEDV)
20%
Saphenous Vein Graft
20%
Endovascular Repair
20%
Cardiac Transplantation
19%
End-stage Heart Failure
19%
Moderate Ischemic Mitral Regurgitation
18%
New York State
18%
United Network for Organ Sharing Database
18%
Randomized Controlled Trial
18%
Brain Arteriovenous Malformation (bAVM)
18%
Health Status
17%
Between-group Difference
16%
Interventional Therapy
16%
Coronary Artery Bypass Graft Surgery
16%
Diabetes
16%
Atrial Fibrillation Ablation
16%
Delirium
16%
Medicare
15%
